BRAINTREE, Mass., March 19 /PRNewswire-FirstCall/ -- Haemonetics Software Solutions is pleased to announce U.S. 510(k) marketing clearance for eLynx(TM), a paperless data capture and temporary storage system for use in blood collection centers. eLynx streamlines and consolidates workflow activities. The automation ensures that standard operating procedures are followed, reducing the likelihood of errors while strengthening regulatory compliance efforts and accuracy.
eLynx utilizes wireless technology on the donor floor to electronically capture all information related to blood collection procedures thereby reducing time for data collection and entry. In addition, eLynx tracks center supply usage, device calibration and preventative maintenance. eLynx can be integrated with any host software system to electronically complete the donation record. Haemonetics markets host systems for plasma collection centers (DMS) and for blood collection centers (SymphonyTM). The eLynx software also works with other center processes and equipment.
“Products and services which increase efficiency and reduce costs in the blood supply chain are an important part of our blood management solutions strategy. eLynx, along with the recently FDA cleared Symphony 2.0, further our commitment to deliver innovative software solutions to blood collectors,” said Tony Pare, Vice President and General Manager of Global Services for Haemonetics. “As the global leader in blood management solutions for our customers, we are pleased to be continually strengthening our product suite with devices, software, and services for blood component collectors and hospitals to improve patients’ outcomes.”
Haemonetics Software Solutions will launch eLynx in limited market release in the second quarter of CY08.
Haemonetics is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
fallon@haemonetics.com
CONTACT: Julie Fallon of Haemonetics Corporation, +1-781-356-9517,
Alternate Tel.: +1-617-320-2401, fallon@haemonetics.com
Web site: http://www.haemonetics.com/
